Retour
Fourchette du Jour
69,45 €
72,59 €
Fourchette 52 Semaines
28,33 €
84,94 €
Volume
1 180 626
Moyenne 50J / 200J
72,52 €
/
59,94 €
Clôture Précédente
72,58 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (633 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -18,5 | 0,2 |
| P/B | — | 2,8 |
| ROE % | — | 3,7 |
| Net Margin % | -145,3 | 3,9 |
| Rev Growth 5Y % | 63,8 | 10,0 |
| D/E | — | 0,2 |
Objectif de Cours des Analystes
Hold
99,85 €
+43.3%
Low: 83,00 €
High: 157,00 €
BPA Prévisionnel
-1,95 €
CA Est.
919,08M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
8,89 €
5,92 € – 10,87 €
|
4,12B | 6 |
| FY2029 |
6,64 €
4,42 € – 8,12 €
|
3,33B | 10 |
| FY2028 |
3,70 €
0,59 € – 6,05 €
|
2,44B | 15 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-24 | -0,71 € | -1,00 € | -40,2% |
| 2025-10-29 | -0,88 € | -0,95 € | -8,0% |
| 2025-08-05 | -0,83 € | -0,95 € | -14,5% |
| 2025-04-29 | -1,00 € | -0,88 € | +12,0% |
| 2025-02-20 | -1,09 € | -1,31 € | -20,2% |
| 2024-11-12 | -1,03 € | -0,86 € | +16,5% |
| 2024-08-01 | -1,09 € | -1,02 € | +6,4% |
| 2024-05-02 | -0,40 € | -0,05 € | +87,5% |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Revenue grew 63,82% annually over 5 years — strong growth
Negative free cash flow of -447,01M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 62,44%
Capital efficient — spends only 0,22% of revenue on capex
Croissance
Revenue Growth (5Y)
63,82%
Revenue (1Y)126,26%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
N/A
ROIC-65,45%
Net Margin-145,26%
Op. Margin-113,35%
Sécurité
Debt / Equity
N/A
Current Ratio2,62
Interest Coverage-10,72
Valorisation
P/E Ratio
-18,53
Forward P/EN/A
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 126,26% | Revenue Growth (3Y) | 634,64% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 63,82% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 502,08M | Net Income (TTM) | -729,31M |
| ROE | N/A | ROA | -77,92% |
| Gross Margin | 94,37% | Operating Margin | -113,35% |
| Net Margin | -145,26% | Free Cash Flow (TTM) | -447,01M |
| ROIC | -65,45% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 2,62 |
| Interest Coverage | -10,72 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -18,53 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | 26,91 |
| PEG Ratio | -0,65 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 14,70 | Fwd Earnings Yield | N/A |
| FCF Yield | -3,31% | ||
| Market Cap | 13,51B | Enterprise Value | 15,67B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 502,08M | 221,90M | 9,30M | 77,65M | 69,72M |
| Net Income | -729,31M | -535,76M | -643,20M | -481,18M | -562,54M |
| EPS (Diluted) | -3,79 | -2,88 | -3,95 | -3,35 | -3,90 |
| Gross Profit | 473,81M | 218,02M | 6,86M | 74,21M | 66,60M |
| Operating Income | -569,09M | -592,97M | -607,37M | -512,20M | -576,63M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 936,03M | 919,34M | 546,38M | 623,04M | 1,01B |
| Total Liabilities | 3,01B | 2,38B | 1,89B | 1,87B | 1,88B |
| Shareholders' Equity | -2,08B | -1,47B | -1,35B | -1,25B | -870,41M |
| Total Debt | 2,73B | 1,73B | 1,74B | 1,72B | 1,73B |
| Cash & Equivalents | 570,12M | 681,10M | 375,94M | 376,69M | 393,77M |
| Current Assets | 753,68M | 720,69M | 477,59M | 548,85M | 888,86M |
| Current Liabilities | 287,97M | 154,40M | 143,84M | 121,43M | 135,07M |